Literature DB >> 3315597

Randomised multicentre trial of anisoylated plasminogen streptokinase activator complex versus heparin. Interim results.

T Meinertz1, W Kasper.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3315597     DOI: 10.2165/00003495-198700333-00039

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  2 in total

1.  French multicenter trial of anistreplase versus heparin in acute myocardial infarction.

Authors:  H Lardoux; Y Louvard; D de Vernejoul; C Picot; M Baudet; M Hiltgen; M Houplon; J Ponsonnaille; M Richard; R Luccioni
Journal:  Cardiovasc Drugs Ther       Date:  1990-10       Impact factor: 3.727

2.  An interim report of the efficacy and safety of anisoylated plasminogen streptokinase activator complex (APSAC).

Authors:  E S Johnson; R J Cregeen
Journal:  Drugs       Date:  1987       Impact factor: 9.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.